Jefferies Group Analysts Lower Earnings Estimates for Envision Healthcare Co. (EVHC)

Envision Healthcare Co. (NYSE:EVHC) – Research analysts at Jefferies Group lowered their FY2017 earnings per share estimates for shares of Envision Healthcare in a research note issued to investors on Tuesday. Jefferies Group analyst B. Tanquilut now anticipates that the company will post earnings per share of $2.48 for the year, down from their previous estimate of $3.00. Jefferies Group has a “Buy” rating and a $41.00 price target on the stock. Jefferies Group also issued estimates for Envision Healthcare’s Q4 2017 earnings at $0.44 EPS and FY2018 earnings at $2.40 EPS.

EVHC has been the topic of several other reports. Bank of America decreased their price target on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 9th. Citigroup cut shares of Envision Healthcare from a “buy” rating to a “neutral” rating and set a $31.00 price target on the stock. in a research note on Thursday, November 2nd. Mizuho set a $57.00 price target on shares of Envision Healthcare and gave the stock a “hold” rating in a research note on Tuesday, October 31st. Cantor Fitzgerald reaffirmed a “hold” rating and set a $30.00 price target on shares of Envision Healthcare in a research note on Tuesday, November 14th. Finally, SunTrust Banks set a $55.00 price target on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Sunday, October 15th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $44.19.

Shares of Envision Healthcare (NYSE:EVHC) opened at $34.52 on Friday. Envision Healthcare has a 12 month low of $23.77 and a 12 month high of $73.00. The stock has a market cap of $3,943.41, a PE ratio of 10.07, a price-to-earnings-growth ratio of 1.06 and a beta of 0.57. The company has a current ratio of 3.01, a quick ratio of 3.00 and a debt-to-equity ratio of 0.89.

Envision Healthcare (NYSE:EVHC) last posted its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.08). Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $2.03 billion. During the same quarter last year, the business posted $1.13 earnings per share. The business’s revenue was up 142.0% compared to the same quarter last year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Sawtooth Solutions LLC boosted its position in shares of Envision Healthcare by 0.7% in the second quarter. Sawtooth Solutions LLC now owns 6,656 shares of the company’s stock worth $417,000 after acquiring an additional 43 shares during the last quarter. Boys Arnold & Co. Inc. boosted its position in shares of Envision Healthcare by 0.6% in the second quarter. Boys Arnold & Co. Inc. now owns 8,125 shares of the company’s stock worth $509,000 after acquiring an additional 50 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in Envision Healthcare by 1.5% in the second quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock valued at $304,000 after buying an additional 70 shares during the period. Utah Retirement Systems raised its holdings in Envision Healthcare by 0.5% in the second quarter. Utah Retirement Systems now owns 21,289 shares of the company’s stock valued at $1,335,000 after buying an additional 100 shares during the period. Finally, M&T Bank Corp raised its holdings in Envision Healthcare by 2.7% in the second quarter. M&T Bank Corp now owns 5,420 shares of the company’s stock valued at $341,000 after buying an additional 141 shares during the period.

Envision Healthcare declared that its board has approved a stock buyback plan on Monday, September 18th that allows the company to repurchase $250.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 4.5% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board believes its stock is undervalued.

TRADEMARK VIOLATION NOTICE: “Jefferies Group Analysts Lower Earnings Estimates for Envision Healthcare Co. (EVHC)” was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/12/22/jefferies-group-analysts-lower-earnings-estimates-for-envision-healthcare-co-evhc.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Earnings History and Estimates for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit